THERAPEUTIC APPLICATIONS AND SAFETY OF FERULIC ACID: AN UPDATED REVIEW
INDIAN DRUGS · 28.07.2026 · 63 (07) · 7-18
DOI: 10.53879/id.63.07.15734 ↗Kurz gefasst
Fachartikel in der Zeitschrift INDIAN DRUGS, online erschienen am 05.08.2026. Verfasst von Mahalaxmi Mohan und 3 weiteren Autor:innen. Die Arbeit nennt 100 Literaturangaben.
Abstract (Originalsprache)
Numerous pharmacological characteristics, such as antioxidant, anti-inflammatory, antibacterial, antidiabetic, anticancer, cholesterol lowering, wound healing, cardioprotective and neuroprotective actions, are displayed by ferulic acid (FA), a crucial hydroxycinnamic acid found in plant cell walls. Through mechanisms like immunological modulation, viral replication suppression, and oxidative stress reduction, recent studies demonstrate its antiviral potential. FA boosts antioxidant defenses and inhibits inflammatory pathways to disrupt viral pathogenesis. Despite its mild safety issues, its low bioavailability, fast metabolism and poor water solubility pose problems for therapeutic use. Developments in drug delivery technologies, including nanoparticle-based formulations and bio-improved derivatives, offer intriguing ways to enhance FA’s pharmacokinetics. To increase FA’s effectiveness, future studies should focus on improving its bioavailability and clinical translation.
Zitieren
APA
Mohan, M., Dange, B. J., Chape, P. R., & Pagar, D. R. (2026). THERAPEUTIC APPLICATIONS AND SAFETY OF FERULIC ACID: AN UPDATED REVIEW. INDIAN DRUGS, 63(07), 7-18. https://doi.org/10.53879/id.63.07.15734
Vancouver
Mohan M, Dange BJ, Chape PR, Pagar DR. THERAPEUTIC APPLICATIONS AND SAFETY OF FERULIC ACID: AN UPDATED REVIEW. INDIAN DRUGS. 2026;63(07):7-18. doi:10.53879/id.63.07.15734
BibTeX
@article{Mohan2026,
author = {Mohan, Mahalaxmi and Dange, Bharti J. and Chape, Punam R. and Pagar, Dhanashree R.},
title = {THERAPEUTIC APPLICATIONS AND SAFETY OF FERULIC ACID: AN UPDATED REVIEW},
journal = {INDIAN DRUGS},
year = {2026},
volume = {63},
number = {07},
pages = {7--18},
doi = {10.53879/id.63.07.15734}
}
EUVIMED